Literature DB >> 9931538

Treatment of ataxia in isolated vitamin E deficiency caused by alpha-tocopherol transfer protein deficiency.

M Schuelke1, E Mayatepek, M Inter, M Becker, E Pfeiffer, A Speer, C Hübner, B Finckh.   

Abstract

Dysfunction of the alpha-tocopherol transfer protein causes ataxia with isolated vitamin E deficiency. A 14-year-old male patient presented with ataxia and mental symptoms caused by a homozygous (552G-->A) alpha-tocopherol transfer protein mutation. After initiation of high-dosage alpha-tocopherol therapy, the organic mental syndrome disappeared and cognitive function improved rapidly. Neurologic recovery, however, was slow and incomplete.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931538     DOI: 10.1016/s0022-3476(99)70424-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

Review 1.  Tocotrienols: the lesser known form of natural vitamin E.

Authors:  Viren Patel; Cameron Rink; Savita Khanna; Chandan K Sen
Journal:  Indian J Exp Biol       Date:  2011-10       Impact factor: 0.818

2.  Ataxia with Vitamin E Deficiency with Predominant Cervical Dystonia.

Authors:  Swati Pradeep; Tarek Ali; Zain Guduru
Journal:  Mov Disord Clin Pract       Date:  2019-12-30

Review 3.  Vitamin E in renal therapeutic regiments.

Authors:  Mohamed Alaa Thabet; James C M Chan
Journal:  Pediatr Nephrol       Date:  2006-09-21       Impact factor: 3.714

4.  Vitamin E and Phosphoinositides Regulate the Intracellular Localization of the Hepatic α-Tocopherol Transfer Protein.

Authors:  Stacey Chung; Mikel Ghelfi; Jeffrey Atkinson; Robert Parker; Jinghui Qian; Cathleen Carlin; Danny Manor
Journal:  J Biol Chem       Date:  2016-06-15       Impact factor: 5.157

Review 5.  Ataxia with vitamin E deficiency: update of molecular diagnosis.

Authors:  I Di Donato; S Bianchi; A Federico
Journal:  Neurol Sci       Date:  2010-05-13       Impact factor: 3.307

Review 6.  Vitamin E: action, metabolism and perspectives.

Authors:  E Herrera; C Barbas
Journal:  J Physiol Biochem       Date:  2001-03       Impact factor: 4.158

7.  Past, present and future therapeutics for cerebellar ataxias.

Authors:  D Marmolino; M Manto
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

8.  Mice lacking alpha-tocopherol transfer protein gene have severe alpha-tocopherol deficiency in multiple regions of the central nervous system.

Authors:  Kishorchandra Gohil; Saji Oommen; Hung T Quach; Vihas T Vasu; Hnin Hnin Aung; Bettina Schock; Carroll E Cross; Govind T Vatassery
Journal:  Brain Res       Date:  2008-02-09       Impact factor: 3.252

9.  Therapies for ataxias.

Authors:  Laurence Martineau; Anne Noreau; Nicolas Dupré
Journal:  Curr Treat Options Neurol       Date:  2014-07       Impact factor: 3.598

10.  Genetic polymorphisms of nerve growth factor receptor (NGFR) and the risk of Alzheimer's disease.

Authors:  Hui-Chi Cheng; Yu Sun; Liang-Chuan Lai; Shih-Yuan Chen; Wen-Chung Lee; Jen-Hau Chen; Ta-Fu Chen; Hua-Hsiang Chen; Li-Li Wen; Ping-Keung Yip; Yi-Min Chu; Wei J Chen; Yen-Ching Chen
Journal:  J Negat Results Biomed       Date:  2012-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.